46
Ie. V. Pylypchuk et al.
14. Gorbyk P, Petranovskaya A, Pilipchuk E, Abramov N, Oranskaya E, Korduban A (2012)
Synthesis of magnetosensitive Gd-containing nanostructures. Chem Phys Technol Surface/Khimiya, Fizyka ta Tekhnologiya Poverhni 2
15. Gorbyk P, Turov V (2011) Nanomaterials and nanocomposites in medicine, biology, ecology.
Naukova Dumka, Kyiv
16. Grumezescu A (2016) Fabrication and self-assembly of Nanobiomaterials. Appl Nanobiomater, William Andrew
17. Huang C, Zhou Y, Tang Z, Guo X, Qian Z, Zhou S (2011) Synthesis of multifunctional Fe3O4
core/hydroxyapatite shell nanocomposites by biomineralization. Dalton Trans 40:5026–5031
18. Iwasaki T (2013) Mechanochemical synthesis of magnetite/hydroxyapatite nanocomposites for
hyperthermia. In: Moshe H, Mastai Y (eds.) Materials science-advanced topics. InTech Open,
UK
19. Kule C, Ondrejickova O, Verner K (1994) Doxorubicin, daunorubicin, and mitoxantrone
cytotoxicity in yeast. Mol Pharmacol 46:1234–1240
20. Levy L, Sahoo Y, Kim K-S, Bergey EJ, Prasad PN (2002) Nanochemistry: synthesis
and characterization of multifunctional nanoclinics for biological applications. Chem Mater
14:3715–3721
21. Lowe MP (2002) MRI contrast agents: the next generation. Aust J Chem 55:551–556
22. Mir A, Mallik D, Bhattacharyya S, Mahata D, Sinha A, Nayar S (2010) Aqueous ferrofluids as
templates for magnetic hydroxyapatite nanocomposites. J Mater Sci Mater Med 21:2365–2369
23. Patel S, Sprung AU, Keller BA, Heaton VJ, Fisher LM (1997) Identification of yeast DNA
topoisomerase II mutants resistant to the antitumor drug doxorubicin: implications for the
mechanisms of doxorubicin action and cytotoxicity. Mol Pharmacol 52:658–666
24. Petranovska A, Abramov N, Turanska S, Gorbyk P, Kaminskiy A, Kusyak N (2015) Adsorption
of cis-dichlorodiammineplatinum by nanostructures based on single-domain magnetite. J
Nanostruct Chem 5:275–285
25. Petranovskaya A, Turelik M, Pilipchuk E, gorbik P, Korduban A, Ivashishin O (2013)
Formation of biomimetic hydroxyapatite on the surface of titanium. Metallophys Latest
Technol 35:1567–1584
26. Pharmacopoeia TE (2008) The European Pharmacopoeia sixth edition, 2008. In: ISBN
27. Pylypchuk E, Gorbyk P (2014) B- and Gd-containing nanomaterials and nanocomposites for
neutron capture therapy. Surface:150–183
28. Pylypchuk E, Petranovska A, Gorbyk P (2012) Synthesis and properties of nanocomposites
based on magnetite modified with DTPA. Nanostrukturnoye Materialovedeniye (Nanostruct
Mater Sci) 3:47
29. Pylypchuk IV, Kołody´ nska D, Gorbyk P (2017) Gd (III) adsorption on the DTPAfunctionalized chitosan/magnetite nanocomposites. Separat Sci Technol 53(7):1006–1016
30. Pylypchuk IV, Kołody´ nska D, Kozioł M, Gorbyk P (2016) Gd-DTPA adsorption on chitosan/magnetite nanocomposites. Nanoscale Res Lett 11:168
31. Pylypchuk IV, Petranovska AL, Turelyk MP, Gorbyk PP (2014) Formation of biomimetic
hydroxyapatite coating on titanium plates. Mater Sci 20:328–332
32. Pylypchuk IV, Petranovskaya A, Gorbyk P, Korduban A, Markovsky P, Ivasishin O (2015)
Biomimetic hydroxyapatite growth on functionalized surfaces of Ti-6Al-4V and Ti-Zr-Nb
alloys. Nanoscale Res Lett 10:338
33. Pylypchuk IV, Zubchuk YO, Petranovskaya A, Turanska S, Gorbyk P (2015) Synthesis
and properties of Fe3O4/HA/pamidronic acid/DTPA-Gd nanocomposites. ¸iÏiâ, ×iÊËÍÃ ÕÃ
ÕÈØÐÑÎÑÆiâ ÒÑÅÈÓØÐi 6:326–335
34. Sadighian S, Hosseini-Monfared H, Rostamizadeh K, Hamidi M (2015) pH-Triggered
magnetic-chitosan nanogels (MCNs) for doxorubicin delivery: physically vs. chemically cross
linking approach. Advan Pharmaceut Bull 5:115
35. Saenko YV, Shutov A, Rastorgueva E (2010) Doxorubicin and menadione decrease cell
proliferation of Saccharomyces cerevisiae by different mechanisms. Cell Tissue Biol 4:332–
336
Précédent

- 64/522

Suivant